Halil Yazici, MD
Department of Internal Medicine, Istanbul Faculty of Medicine
4
0
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Safak Mirioglu, MD
Department of Internal Medicine, Istanbul Faculty of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Sabahattin Kaymakoglu, MD
Department of Internal Medicine, Istanbul Faculty of Medicine
Shared therapeutic areas:
Worked with same sponsors:
William A Gahl, M.D.
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
Ming-Lung Yu, MD, PhD
Kaohsiung Medical University
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Mostafa Gabr, MD
Cairo University
Shared therapeutic areas:
Wahid Doss, MD
Cairo University
Shared therapeutic areas:
Pei-Jer Chen, MD, PhD
National Taiwan University Hospital
Shared therapeutic areas:
Kazuoki Kondo, M.D.
Tanabe Pharma Corporation
Shared therapeutic areas:
Shih-Jer Hsu, MD
National Taiwan University Hospital, Yun-Lin Branch
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection
Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease
Rituximab in Refractory Primary Membranous Nephropathy
Direct Acting Antivirals for HCV Infection in Kidney Transplant Recipients
All 4 trials loaded